The utility of the nonattenuation corrected 18F-FDG PET images in the characterization of solitary pulmonary lesions

Nuclear Medicine Communications

Volumn 31, Issue 11, 2010, Pages 945-951

  Huang, Yu Erh ^a   Pu, Yong Lin ^b   Huang, Yu Jie ^a   Chen, Chih Feng ^a   Pu, Quan Hong ^c   Konda, Sheela D ^b   Appelbaum, Daniel E ^b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b UNIVERSITY OF CHICAGO   (United States)

^c Da Xiang Shan Town   (China)

Author keywords

18F fluorodeoxyglucose; positron emission tomography; solitary pulmonary nodules

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BENIGN TUMOR; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; LUNG ADENOCARCINOMA; LUNG CARCINOMA; LUNG METASTASIS; LUNG NODULE; LUNG NON SMALL CELL CANCER; LUNG SCINTISCANNING; LUNG TUMOR; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; SENSITIVITY AND SPECIFICITY; SPINDLE CELL CARCINOMA; TUMOR DIAGNOSIS; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; DIAGNOSIS, DIFFERENTIAL; FALSE NEGATIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; SOLITARY PULMONARY NODULE;

EID: 77957983377     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32833ed57d     Document Type: Article

References (38)

1. Gupta NC, Frank AR, Dewan NA, Redepenning LS, Rothberg ML, Mailliard JA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992; 184:441-444.
2. Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick MP. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest 1993; 104:997-1002.
3. Lowe VJ, Fletcher JW, Gobar L, Lawson M, Kirchner P, Valk P, et al. Prospective investigation of positron emission tomography in lung nodules. J Clin Oncol 1998; 16:1075-1084. (Pubitemid 28108743)
4. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001; 285:914-924.
5. Gupta NC, Maloof J, Gunel E. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET. J Nucl Med 1996; 37:943-948.
6. Kim SK, Allen-Auerbach M, Goldin J, Fueger BJ, Dahlbom M, Brown M, et al. Accuracy of PET/CT in characterization of solitary pulmonary lesions. J Nucl Med 2007; 48:214-220.
7. Matthies A, Hickeson M, Cuchiara A, Alavi A. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002; 43:871-875.
8. Bryant AS, Cerfolio RJ. The maximum standardized uptake values on integrated FDG-PET/CT is useful in differentiating benign from malignant pulmonary nodules. Ann Thorac Surg 2006; 82:1016-1020.
9. Nomori H,Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Evaluation of 18F fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to the CT images. Lung Cancer 2004; 45:19-27.
10. Dewan NA, Shehan CJ, Reeb SD, Gobar LS, Scott WJ, Ryschon K. Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan. Chest 1997; 112:416-422.
11. Kotzerke J, Guhlmann A, Moog F, Frickhofen N, Reske SN. Role of attenuation correction for fluorine-18 fluorodeoxyglucose positron emission tomography in the primary staging of malignant lymphoma. Eur J Nucl Med 1999; 26:31-38.
12. Lonneux M, Borbath I, Bol A, Coppens A, Sibomana M, Bausart R, et al. Attenuation correction in whole-body FDG oncological studies: the role of statistical reconstruction. Eur J Nucl Med 1999; 26:591-598.
13. Joshi U, Raijmakers PG, Riphagen II, Teule GJ, van Lingen A, Hoekstra OS. Attenuation-corrected vs. nonattenuation-corrected 2-deoxy-2-[F-18]fluoro- D-glucose-positron emission tomography in oncology: a systematic review. Mol Imaging Biol 2007; 9:99-105.
14. Reinhardt MJ, Wiethoelter N, Matthies A, Joe AY, Strunk H, Jaeger U, et al. PET recognition of pulmonary metastases on PET/CT imaging: impact of attenuation-corrected and non-attenuation-corrected PET images. Eur J Nucl Med Mol Imaging 2006; 33:134-139.
15. Watson CC. New, faster, image-based scatter correction for 3D PET. IEEE Trans Nucl Sci 2000; 47:1587-1594.
16. Tan BB, Flaherty KR, Kazerooni EA, Iannettoni MD. The solitary pulmonary nodule. Chest 2003; 123:89S-96S.
17. Patz EF Jr, Lowe VJ, Hoffman JM, Paine SS, Burrowes P, Coleman RE, et al. Focal pulmonary abnormalities: evaluation with 18F fluorodeoxyglucose PET scanning. Radiology 1993; 188:487-490.
18. Duhaylongsod FG, Lowe VJ, Patz EF Jr, Vaughn AL, Coleman RE,Wolfe WG. Detection of primary and recurrent lung cancer by means of 18F fluorodeoxyglucose positron emission tomography (FDG PET). J Thorac Cardiovasc Surg 1995; 110:130-139.
19. Bury T, Dowlati A, Paulus P, Corhay JL, Benoit T, Kayembe JM, et al. Evaluation of the solitary pulmonary nodule by positron emission tomography imaging. Eur Respir J 1996; 9:410-414. (Pubitemid 26117781)
20. Detterbeck FC, Falen S, Rivera MP, Halle JS, Socinski MA. Seeking a home for a PET, part 1: defining the appropriate place for positron emission tomography imaging in the diagnosis of pulmonary nodules or masses. Chest 2004; 125:2294-2299. (Pubitemid 38788202)
21. Kim BT, Kim Y, Lee KS, Yoon SB, Cheon EM, Kwon OJ, et al. Localized form of bronchioloalveolar carcinoma: FDG PET findings. AJR Am J Roentgenol 1998; 170:935-939.
22. Klein JS, Braff S. Imaging evaluation of the solitary pulmonary nodule. Clin Chest Med 2008; 29:15-38.
23. Hustinx R, Dolin RJ, Benard F, Bhatnagar A, Chakraborty D, Smith RJ, et al. Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis. Eur J Nucl Med 2000; 27:1365-1371.
24. Bleckmann C, Dose J, Bohuslavizki KH, Buchert R, Klutmann S, Mester J, et al. Effect of attenuation correction on lesion detectability in FDG PET of breast cancer. J Nucl Med 1999; 40:2021-2024.
25. Farquhar TH, Llacer J, Hoh CK, Czernin J, Gambhir SS, Seltzer MA, et al. ROC and localization ROC analyses of lesion detection in whole-body FDG PET: effects of acquisition mode, attenuation correction and reconstruction algorithm. J Nucl Med 1999; 40:2043-2052.
26. Schauwecker DS, Siddiqui AR, Wagner JD, Davidson D, Jung SH, Carlson KA, et al. Melanoma patients evaluated by four different positron emission tomography reconstruction techniques. Nucl Med Commun 2003; 24:281-289.
27. Schrevens L, Lorent N, Dooms C, Vansteenkiste J. The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer. Oncologist 2004; 9:633-643.
28. Raylman RR, Kison PV,Wahl RL. Capabilities of two- and three-dimensional FDG-PET for detecting small lesions and lymph nodes in the upper torso: a dynamic phantom study. Eur J Nucl Med 1999; 26:39-45.
29. Bengel FM, Ziegler SI, Avril N, Weber W, Laubenbacher C, Schwaiger M. Whole-body positron emission tomography in clinical oncology: comparison between attenuation-corrected and uncorrected images. Eur J Nucl Med 1997; 24:1091-1098.
30. Wong TZ, Coleman RE, Hagge RJ, Borges-Neto S, Hanson MW. PET image interpretation. Attenuation-corrected (ATN) vs. non-attenuation corrected (NATN) images. Clin Positron Imaging 2000; 3:181.
31. Wahl RL. To AC or not to AC: that is the question. J Nucl Med 1999; 40:2025-2028.
32. Bai C, Kinahan PE, Brasse D, Comtat C, Townsend DW, Meltzer CC, et al. An analytic study of the effects of attenuation on tumor detection in wholebody PET oncology imaging. J Nucl Med 2003; 44:1855-1861.
33. Kinahan PE, Townsend DW, Beyer T, Sashin D. Attenuation correction for a combined 3D PET/CT scanner. Med Phys 1998; 25:2046-2053.
34. Goerres GW, Kamel E, Heidelberg TN, Schwitter MR, Burger C, von Schulthess GK. PET-CT image co-registration in the thorax: influence of respiration. Eur J Nucl Med Mol Imaging 2002; 29:351-360.
35. Goerres GW, Kamel E, Seifert B, Burger C, Buck A, Hany TF, et al. Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system. J Nucl Med 2002; 43:1469-1475.
36. Erdi YE, Nehmeh SA, Pan T, Pevsner A, Rosenzweig KE, Mageras G, et al. The CT motion quantitation of lung lesions and its impact on PET-measured SUVs. J Nucl Med 2004; 45:1287-1292.
37. Goerres GW, Burger C, Kamel E, Seifert B, Kaim AH, Buck A, et al. Respiration-induced attenuation artifact at PET/CT: technical considerations. Radiology 2003; 226:906-910.
38. Yap CS, Schiepers C, Fishbein MC, Phelps ME, Czernin J. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma? Eur J Nucl Med Mol Imaging 2002; 29:1166-1173.